Company Selectimmune Pharma AB (publ)

SELECT B

SE0012622785

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

Selectimmune Pharma AB is a Sweden-based pharmaceutical company. The Company develops new ways of equipping the host immune system to fight off the infections. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The Company is committed to exploring new medical innovations and solutions for the treatment of acute and chronic infections and their sequels. Selectimmune Pharma develops immunotherapies as alternatives to antibiotics.

Number of employees: 2

Managers	Title	Age	Since
Jan Gustaf Zetterberg LAW	General Counsel	73	01/17/01

Members of the board	Title	Age	Since
Catharina Svanborg CHM	Chairman	75	10/17/10
Helena Lomberg BRD	Director/Board Member	78	01/17/01
Carl-Johan Wachtmeister BRD	Director/Board Member	69	01/18/01
Magnus Nylén BRD	Director/Board Member	-	23/22/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	2,000,000	0	0	27.47 %
Stock B	1	15,459,225	4,795,452 ( 31.02 %)	0

SelectImmune Pharma AB

Klinikgatan 32

222 42, Lund

http://www.selectimmune.com

address Selectimmune Pharma AB (publ)(SELECT B)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+55.19%	801B
NOVO NORDISK A/S	+47.26%	631B
JOHNSON & JOHNSON	-6.09%	359B
MERCK & CO., INC.	+21.92%	337B
ASTRAZENECA PLC	+18.40%	245B
ROCHE HOLDING AG	+3.64%	231B
NOVARTIS AG	+12.98%	219B
AMGEN INC.	+10.86%	171B
PFIZER, INC.	-2.78%	161B

Other Pharmaceuticals